Severini, Giacomo http://orcid.org/0000-0002-2289-9331
Koenig, Alexander
Adans-Dester, Catherine http://orcid.org/0000-0001-6816-0586
Cajigas, Iahn http://orcid.org/0000-0002-5808-453X
Cheung, Vincent C. K. http://orcid.org/0000-0002-6031-7320
Bonato, Paolo http://orcid.org/0000-0002-1818-1714
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PBEZ3_137336)
U.S. Department of Health & Human Services | National Institutes of Health (1F31NS058275)
Article History
Received: 12 May 2019
Accepted: 21 February 2020
First Online: 25 March 2020
Competing interests
: The authors declare no competing financial interests. The authors declare the following non-competing financial interests: G.S. has received grant support (as Principal Investigator) from the EU (H2020) and Enterprise Ireland. A.K. has received grant support (as Principal Investigator) from the German Federal Ministry of Research and Education, the Bavarian Ministry of Economic Affairs, the European Space Agency and the German Federal Ministry of Economic Affairs and Energy. He is founder, shareholder and CEO of Reactive Robotics GmbH (Munich, Germany). C.A.D. has no disclosures. I.C. has received grant support (as Principal Investigator) from the National Institutes of Health (NIH) and the Lemelson Foundation. He has also received grant support (as a co-Investigator) from Medtronic (Minneapolis, MN). V.C. has received grant support (as a Principal Investigator) from the Hong Kong Research Grants Council, the Chinese University of Hong Kong, the Guangdong Provincial Hospital of Traditional Chinese Medicine (Guangzhou, China), and the Golden King (Asia Pacific) Ltd. (Hong Kong). He has also received grant support (as a co-Investigator) from the Shun Hing Institute of Advanced Engineering (Hong Kong). He is also a shareholder and adviser (uncompensated) of Pureform Technology Ltd. (Hong Kong). P.B. has received grant support from the American Heart Association, the Department of Defense, the Michael J Fox Foundation, the National Institutes of Health (NIH), the National Science Foundation (NSF), and the Peabody Foundation including sub-awards on NIH and NSF SBIR grants from Barrett Technology (Newton MA), BioSensics (Watertown MA) and Veristride (Salt Lake City UT). He has also received grant support from Emerge Diagnostics (Carlsbad CA), MC10 (Lexington MA), Mitsui Chemicals (Tokyo Japan), Pfizer (New York City NY), Shimmer Research (Dublin Ireland), and SynPhNe (Singapore). The authors declare the following non-financial interests: G.S., A.K., C.A.D., I.C. and V.C. have no disclosures. P.B. serves in an advisory uncompensated role the Michael J Fox Foundation and the NIH-funded New England Pediatric Device Consortium. He also serves in an uncompensated role on the Scientific Advisory Boards of ABLE Human Motion (Barcelona, Spain), FormSense (San Diego CA, USA), Hocoma AG (Zurich, Switzerland), and Trexo (Toronto, Canada).